SPC494
Sugemalimab
Status:
UmsóknApplication date:
6.1.2025Application published:
15.2.2025
Medicine name:
CejemlyMedicine for children:
No
Timeline
Today
6.1.2025Application
15.2.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1833Date:
24.7.2024
Owner
Name:
Wuxi Biologics (Shanghai) Co. Ltd.Address:
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Shanghai 200131 CN
Name:
Wuxi Biologics Ireland LimitedAddress:
Mullagharlin, Dundalk, Co Louth A91 X56F IE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3332006